Quantifying changes in local basal ganglia structural connectivity in the 6-hydroxydopamine model of Parkinson's Disease using correlational tractography

被引:0
|
作者
Moshchin, Mikhail [1 ]
Cheng, Kevin P. [1 ]
Osting, Susan [1 ]
Laluzerne, Matthew [1 ]
Hurley, Samuel A. [1 ]
Singh, Ajay Paul [1 ]
Trevathan, James K. [1 ]
Brzeczkowski, Andrea [1 ]
Yu, John-Paul J. [1 ]
Lake, Wendell B. [1 ]
Ludwig, Kip A. [1 ]
Suminski, Aaron J. [1 ]
机构
[1] Univ Wisconsin Madison, Madison, WI 53706 USA
来源
2023 11TH INTERNATIONAL IEEE/EMBS CONFERENCE ON NEURAL ENGINEERING, NER | 2023年
关键词
Parkinson's disease; 6-OHDA; ex-vivo magnetic resonance imaging; diffusion tensor imaging; quantitative anisotropy; deterministic tractography; DEGENERATION; DOPAMINE;
D O I
10.1109/NER52421.2023.10123839
中图分类号
TP18 [人工智能理论];
学科分类号
081104 ; 0812 ; 0835 ; 1405 ;
摘要
In recent years, tractography based on diffusion magnetic resonance imaging (dMRI) has become a popular tool for studying microstructural changes resulting from brain diseases like Parkinson's Disease (PD). Quantitative anisotropy (QA) is a parameter that is used in deterministic fiber tracking as a measure of connection between brain regions. It remains unclear, however, if microstructural changes caused by lesioning the median forebrain bundle (MFB) to create a Parkinsonian rat model can be resolved using tractography based on ex-vivo diffusion MRI. This study aims to fill this gap and enable future mechanistic research on structural changes of the whole brain network rodent models of PD. Specifically, it evaluated the ability of correlational tractography to detect structural changes in the MFB of 6-hydroxydopamine (6-OHDA) lesioned rats. The findings reveal that correlational tractography can detect structural changes in lesioned MFB and differentiate between the 6-OHDA and control groups. Imaging results are supported by behavioral and histological evidence demonstrating that 6-OHDA lesioned rats were indeed Parkinsonian. The results suggest that QA and correlational tractography is appropriate to examine local structural changes in rodent models of neurodegenerative disease. More broadly, we expect that similar techniques may provide insight on how disease alters structure throughout the brain, and as a tool to optimize therapeutic interventions.
引用
收藏
页数:4
相关论文
共 50 条
  • [21] Characterization of the gastrointestinal dysfunction in the 6-hydroxydopamine rat model of Parkinson's disease
    Chai, X.
    Diwakarla, S.
    Pustovit, R.
    McQuade, R.
    Di Natale, M.
    Ermine, C.
    Parish, C.
    Finkelstein, D.
    Furness, J.
    MOVEMENT DISORDERS, 2019, 34 : S629 - S629
  • [22] Exercise-Induced Neuroprotection in the 6-Hydroxydopamine Parkinson's Disease Model
    Rezaee, Zeinab
    Marandi, Sayed Mohammad
    Alaei, Hojjatallah
    Esfarjani, Fahimeh
    NEUROTOXICITY RESEARCH, 2020, 38 (04) : 850 - 858
  • [23] GDNF reduces oxidative stress in a 6-hydroxydopamine model of Parkinson's disease
    Smith, Michael P.
    Cass, Wayne A.
    NEUROSCIENCE LETTERS, 2007, 412 (03) : 259 - 263
  • [24] Mitochondrial Dynamics and Mitophagy in the 6-Hydroxydopamine Preclinical Model of Parkinson's Disease
    Galindo, Maria F.
    Solesio, Maria E.
    Atienzar-Aroca, Sandra
    Zamora, Maria J.
    Jordan Bueso, Joaquin
    PARKINSONS DISEASE, 2012, 2012
  • [25] Therapeutic potential of bromelain in 6-hydroxydopamine rat model of parkinson's disease
    Cicek, B.
    Gul, M.
    Taghizadehghalehjoughi, A.
    Okkay, U.
    Yildirim, S.
    Okkay, I. F.
    Ertugrul, M. S.
    Aydin, I. C.
    Bayram, C.
    Arslan, Y. K.
    Hacimuftuoglu, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020, 40 : S438 - S439
  • [26] The effect of thrombin on a 6-hydroxydopamine model of Parkinson's disease depends on timing
    Cannon, Jason R.
    Hua, Ya
    Richardson, Rudy J.
    Xi, Guohua
    Keep, Richard F.
    Schallert, Timothy
    BEHAVIOURAL BRAIN RESEARCH, 2007, 183 (02) : 161 - 168
  • [27] Resting State Functional and Structural Connectivity Changes of Cerebellum Basal Ganglia Interconnecting Network in Parkinson's Disease
    Radhakrishnan, V.
    Krishnan, S.
    Thomas, B.
    Gallea, C.
    Kesavadas, C.
    Kishore, A.
    MOVEMENT DISORDERS, 2020, 35 : S267 - S268
  • [28] Metabolic–dopaminergic mapping of the 6-hydroxydopamine rat model for Parkinson’s disease
    Cindy Casteels
    Erwin Lauwers
    Guy Bormans
    Veerle Baekelandt
    Koen Van Laere
    European Journal of Nuclear Medicine and Molecular Imaging, 2008, 35 : 124 - 134
  • [29] Afobazole Restores the Dopamine Level in a 6-Hydroxydopamine Model of Parkinson’s Disease
    M. V. Voronin
    I. A. Kadnikov
    S. B. Seredenin
    Neurochemical Journal, 2019, 13 : 49 - 56
  • [30] Measures of striatal insulin resistance in a 6-hydroxydopamine model of Parkinson's disease
    Morris, J. K.
    Zhang, H.
    Gupte, A. A.
    Bomhoff, G. L.
    Stanford, J. A.
    Geiger, P. C.
    BRAIN RESEARCH, 2008, 1240 : 185 - 195